Sign inCreate account

Report workspace tools

NCT00267293COMPLETEDanonymous

Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever

Sponsor

Source record

Penn State University

Phase

Source record

PHASE4

Modality

AI-normalized

small molecule

Target

AI-normalized

Acetaminophen, Ibuprofen

Indication / condition

AI-normalized

Fever

Intervention

Source record

Acetaminophen, Ibuprofen

Source & freshness

Source record

NCT ID

NCT00267293

Original source

ClinicalTrials.gov

Source last updated

May 09, 2012

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT00267293

Title

Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever

Sponsor

Penn State University

Status

COMPLETED

Phase

PHASE4

Condition raw

Fever

Condition normalized

Fever

Modality raw

small molecule

Modality normalized

small molecule

Target raw

Acetaminophen, Ibuprofen

Target normalized

Acetaminophen, Ibuprofen

Interventions

Acetaminophen, Ibuprofen

Public preview

Source record

Currently, when a child has fever either ibuprofen (e.g. Motrin, Advil) or acetaminophen (e.g. Tylenol) is given. Both Ibuprofen and Acetaminophen are approved for over the counter use for treatment of fever by the Food and Drug Administration (FDA). This study hopes to determine whether giving both medications together is better than giving one medication alone for the treatment of fever.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT00267293

Status

COMPLETED

Phase

PHASE4

Sponsor

Penn State University

Executive brief

Investment-Ready Snapshot

Currently, when a child has fever either ibuprofen (e.g. Motrin, Advil) or acetaminophen (e.g. Tylenol) is given. Both Ibuprofen and Acetaminophen are approved for over the counter use for treatment of fever by the Food and Drug Administration (FDA). This study hopes to determine whether giving both medications together is better than giving one medication alone for the treatment of fever.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedMay 09, 2012
Internal syncJun 09, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT00267293

Indication

Fever

Modality

small molecule

Target

Acetaminophen, Ibuprofen

Intervention

Acetaminophen, Ibuprofen

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.